Sign Up Today and Learn More About Orionis Biosciences Stock
Invest in or calculate the value of your shares in Orionis Biosciences or other pre-IPO companies through EquityZen's platform.
Orionis Biosciences Stock (ORIB)
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
About Orionis Biosciences Stock
Founded
2015
Headquarters
Boston, MA, US
Total Funding
23.7M
Industries
Science and Engineering, Health Care, Biotechnology
Orionis Biosciences Press Mentions
Stay in the know about the latest news on Orionis Biosciences
Orionis Biosciences partners with Genentech on glue meds
thepharmaletter • May 23, 2025
Molecular Glues Competitive Landscape 2025: Exploring 65+ Drugs and 50+ Biotech Players in the Molecular Glue Space
globenewswire • Mar 06, 2025
ChemDiv Marks a Milestone as Orionis Biosciences' Novel Immunotherapy Enters Phase I Clinical Trials
uk • Mar 04, 2024
Orionis Biosciences Announces First Patient Dosed in Phase 1 Clinical Trial of ORB-011 in Patients with Advanced ...
businesswire • Mar 04, 2024
Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines
finance • Mar 04, 2024
Orionis Biosciences Management
Leadership team at Orionis Biosciences
Founder, President and CEO
Nikolai Kley
Join now and verify your accreditation status to gain access to:
- Orionis Biosciences Current Valuation
- Orionis Biosciences Stock Price
- Orionis Biosciences Management
- Available deals in Orionis Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Orionis Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Orionis Biosciences Revenue and Financials
- Orionis Biosciences Highlights
- Orionis Biosciences Business Model
- Orionis Biosciences Risk Factors
- Orionis Biosciences Research Report from SACRA Research
Trading Orionis Biosciences Stock
How to invest in Orionis Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Orionis Biosciences through EquityZen funds. These investments are made available by existing Orionis Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Orionis Biosciences stock?
Shareholders can sell their Orionis Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
